Schedule 13G ownership disclosure
Orexigen Theraptcs
Security class unavailable · CUSIP: 686164302
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 174,373
- Percent of class
- 1.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-17-008137
- Form type
- SC 13G
- Filer
- Foresite Capital Fund II, L.P.
- CIK
- CIK 1594914
- Filed
- Feb 14, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership